Roivant Sciences Stock News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roivant sciences stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roivant Sciences Stock Today - Breaking & Trending Today

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives $16.90 Consensus Target Price from Analysts

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives $16.90 Consensus Target Price from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Eric Venker , Analyst Recommendations For Roivant Sciences , Securities Exchange Commission , News Ratings For Roivant Sciences Daily , Allspring Global Investments Holdings , Investment Advisers , Path Wealth Partners , Roivant Sciences Stock , Wolfe Research , Roivant Sciences Ltd , Institutional Investors Weigh In On Roivant Sciences , Covestor Ltd , Headlands Technologies , Goldman Sachs Group , Roivant Sciences , Get Free Report , Exchange Commission , Global Investments Holdings , Premier Path Wealth Partners , Get Free , Sciences Ltd , Roivant Sciences Daily ,

Roivant Sciences (NASDAQ:ROIV) PT Raised to $15.00

Roivant Sciences (NASDAQ:ROIV – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $14.00 to $15.00 in a report released on Wednesday, Benzinga reports. They currently have a buy rating on the stock. ROIV has been the subject of several other reports. Piper Sandler started coverage on Roivant Sciences in a research […] ....

United States , Piper Sandler , Eric Venker , Deutsche Bank Aktiengesellschaft , Deerfield Management Companylp Series , Morgan Stanley , Insider Activity At Roivant Sciences , Analyst Recommendations For Roivant Sciences , Roivant Sciences Stock , Citigroup Inc , Roivant Sciences Ltd , News Ratings For Roivant Sciences Daily , Roivant Sciences , Free Report , Truist Financial , Moderate Buy , Get Free Report , Global Partners , Sciences Ltd , Roivant Sciences Daily , Nasdaq Roiv , Boost Price Target ,

HC Wainwright Boosts Roivant Sciences (NASDAQ:ROIV) Price Target to $18.00

Roivant Sciences (NASDAQ:ROIV – Free Report) had its price target upped by HC Wainwright from $17.00 to $18.00 in a research note released on Wednesday morning, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Roivant Sciences’ Q1 2025 earnings at ($0.25) EPS, Q2 2025 earnings […] ....

United States , Eric Venker , Piper Sandler , Wolfe Research , Roivant Sciences , Citigroup Inc , Royal Bank , Investment Advisers , Deutsche Bank Aktiengesellschaft , Analyst Recommendations For Roivant Sciences , Roivant Sciences Ltd , Dagco Inc , Roivant Sciences Stock , News Ratings For Roivant Sciences Daily , Securities Exchange Commission , Institutional Trading Of Roivant Sciences , Headlands Technologies , Insider Transactions At Roivant Sciences , Free Report , Bank Aktiengesellschaft , Moderate Buy , Get Free Report , Exchange Commission , Sciences Ltd , Roivant Sciences Daily ,

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives $16.56 Consensus PT from Brokerages

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives $16.56 Consensus PT from Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Eric Venker , Piper Sandler , Vivek Ramaswamy , Analyst Recommendations For Roivant Sciences , Hedge Funds Weigh In On Roivant Sciences , Headlands Technologies , News Ratings For Roivant Sciences Daily , Roivant Sciences Ltd , Investment Advisers , Allspring Global Investments Holdings , Dagco Inc , Roivant Sciences , Roivant Sciences Stock , Royal Bank , Wolfe Research , Insider Activity At Roivant Sciences , Get Free Report , Marketbeat Ratings , Global Investments Holdings , Get Free , Sciences Ltd , Roivant Sciences Daily ,

Silverarc Capital Management LLC Invests $1.17 Million in Roivant Sciences Ltd. (NASDAQ:ROIV)

Silverarc Capital Management LLC purchased a new position in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 100,000 shares of the company’s stock, valued at approximately $1,168,000. A number of other institutional investors have also recently […] ....

United States , Vivek Ramaswamy , Piper Sandler , Eric Venker , Insider Transactions At Roivant Sciences , Roivant Sciences , Citigroup Inc , Roivant Sciences Stock , Roivant Sciences Profile , News Ratings For Roivant Sciences Daily , Deutsche Bank Aktiengesellschaft , Wolfe Research , Quarter For Roivant Sciences , Exchange Commission , Royal Bank , Allspring Global Investments Holdings , Silverarc Capital Management , Roivant Sciences Ltd , Free Report , Global Investments Holdings , Street Group , Bank Aktiengesellschaft , Sciences Ltd , Visit Holdingschannel , Roivant Sciences Daily , Nasdaq Roiv ,